GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (OTCPK:CLRPF) » Definitions » Dividend Yield %

CLRPF (Clarity Pharmaceuticals) Dividend Yield % : 0.00% (As of Dec. 12, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Clarity Pharmaceuticals Dividend Yield %?

As of today (2024-12-12), the Trailing Annual Dividend Yield of Clarity Pharmaceuticals is 0.00%.

The historical rank and industry rank for Clarity Pharmaceuticals's Dividend Yield % or its related term are showing as below:

CLRPF's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.4
* Ranked among companies with meaningful Dividend Yield % only.

Clarity Pharmaceuticals's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00.

As of today (2024-12-12), the Forward Dividend Yield % of Clarity Pharmaceuticals is 0.00%.

Clarity Pharmaceuticals's Dividends per Share for the six months ended in Dec. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Clarity Pharmaceuticals Dividend Yield % Historical Data

The historical data trend for Clarity Pharmaceuticals's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Dividend Yield % Chart

Clarity Pharmaceuticals Annual Data
Trend Jun22 Jun23 Jun24
Dividend Yield %
- - -

Clarity Pharmaceuticals Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Dividend Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Clarity Pharmaceuticals's Dividend Yield %

For the Biotechnology subindustry, Clarity Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clarity Pharmaceuticals's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clarity Pharmaceuticals's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Clarity Pharmaceuticals's Dividend Yield % falls into.



Clarity Pharmaceuticals Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Clarity Pharmaceuticals  (OTCPK:CLRPF) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Clarity Pharmaceuticals Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Clarity Pharmaceuticals's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clarity Pharmaceuticals Business Description

Traded in Other Exchanges
Address
4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology. It operates as a single segment, which is Development of Radiopharmaceuticals. Geographically, it operates in Australia and the United States.